| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | 0.28 | 2e-11 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | 0.26 | 3e-11 |
| mRNA | HG-6-64-1 | GDSC1000 | pan-cancer | AAC | 0.25 | 3e-10 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | 0.25 | 3e-09 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | 0.2 | 3e-08 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | 0.2 | 2e-07 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | 0.2 | 6e-07 |
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | 0.2 | 1e-06 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | 0.2 | 1e-06 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | 0.25 | 4e-06 |